Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM) (PARADIGM)
Sponsor: Cedars-Sinai Medical Center
A observational or N/A phase clinical study on Coronary Heart Disease, this trial is ongoing. The trial is conducted by Cedars-Sinai Medical Center and has accumulated 11 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Unknown
-
Feb 2026 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Jan 2026 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — Feb 2026 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 6 earlier versions
-
Jan 2021 — Jul 2024 [monthly]
Active Not Recruiting
-
Jul 2018 — Jan 2021 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Mar 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cedars-Sinai Medical Center
- Centro Cardiologico Monzino
- German Heart Institute
- Hospital da Luz, Portugal
- Montreal Heart Institute
- National Institute of Cardiology, Laranjeiras, Brazil
- University of British Columbia
- University of California, Los Angeles
- Weill Medical College of Cornell University
- Yonsei University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.